Efficacy of ipilimumab 3 mg/kg following progression on low-dose ipilimumab in metastatic melanoma

Lai-Kwon, J; Jacques, S; Carlino, M; Benannoune, N; Robert, C; Allayous, C; Baroudjian, B; Lebbe, C; Zimmer, L; Eroglu, Z; Topcu, TO; Dimitriou, F; Haydon, A; Lo, SN; Menzies, AM; Long, GV

Long, GV (通讯作者)，Melanoma Inst Australia, 40 Rocklands Rd, Wollstonecraft, NSW 2065, Australia.

EUROPEAN JOURNAL OF CANCER, 2023; 186 (): 12

Abstract

Background: Differing doses of ipilimumab (IPI) are used in combination with an anti-PD1 antibody in advanced melanoma. There is no data on the outcom......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索